Expert-led tax essentials delivering practical insights and strategic foresight. Learn more.
Sustainability reporting and assurance 2025 highlights & 2026 outlook for Australia
Australian Securities and Investments Commission (ASIC) and the Auditing and Assurance Standards Board (AUASB) have both recently published FAQs providing guidance on the use of the different auditors for financial reporting audit and sustainability reporting assurance.
The biotech industry faces significant challenges, including regulatory pressures, supply chain disruptions, rising costs and shifting investment landscapes.
The following Australian Standards on Sustainability Assurance (ASSA) and the Relevant Ethical Requirements were approved by the Auditing and Assurance Standards Board (AUASB) on 28 January 2025.
The Auditing and Assurance Standards Board (AUASB) board meeting on 16 December 2024 confirmed the final phasing for mandatory assurance of information in sustainability reports. A final draft standard incorporating these changes will be presented to the AUASB for approval in late January 2025.
Navigating the funding landscape can be tricky for biotech companies at all stages, from initial research and clinical trials to scaling up capabilities. Our recent roundtable discussions with over 90 Biotech CEOs, held in partnership with AusBiotech, shed light on the challenges and opportunities shaping the industry.
